Producing Great Outcomes for Patients Locally and Globally with Made-in-Canada Treatments

Canadians are well-served by the Federal Government’s goal to position Canada as a world leader in the development and manufacturing of innovative products and services.

Bausch Health shares this focus in our development, distribution, and manufacturing of pharmaceutical products and technologies for Canadians. Our suite of products and technologies spans several therapeutic areas including dermatology, cardiovascular and mental health, to name a few. Notably, we have significant manufacturing infrastructure in Canada. This allows for effective local production, resulting in faster access for patients.

Seventy percent of the products we make in Canada are manufactured for export, underlining the role our Canadian operations play in the global business of Bausch Health. We also play an important role here at home. 

We work hard to ensure and build on the quality and excellence of our two Canadian manufacturing sites, through projects such as upgrading serialization technology that enables specific product tracking. Excellence in manufacturing activity ensures supply, which is critical not just for commercial outcomes but also, and more importantly, for patients. For example, we can pivot to produce products in a therapeutic area in our focus to increase supply and provide additional options to patients who rely on treatments to improve their health and lives. Our ability to do this results in better health outcomes for Canadian patients.

At Bausch Health, we are delivering on our commitments as we build an innovative company dedicated to advancing local and global health needs and outcomes, when and where we’re needed. We’re proud of the work we do and the role we play in positioning Canada as a world leader in modern health care.


By Richard Lajoie, President, Bausch Health

Bausch Health is a Sponsor of Research Canada’s Your Candidates, Your Health 2019 Federal Election Campaign. To learn more, visit